natgillin/translations-raw huggingface dataset:
The study showed that the combination of Kyprolis and dexamethasone is more effective at improving progression-free survival than bortezomib and dexamethasone: patients receiving Kyprolis plus dexamethasone lived for an average of 18.7 months without their disease getting worse, compared with 9.4 months for patients receiving bortezomib and dexamethasone.
Ispitivanje je pokazalo da je kombinacija lijeka Kyprolis i deksametazona djelotvornija u poboljšanju stope preživljenja bez progresije bolesti od bortezomiba i deksametazona: bolesnici koji su primili Kyprolis s deksametazonom živjeli su u prosjeku 18,7 mjeseci bez pogoršanja bolesti, u usporedbi s 9,4 mjeseca za bolesnike koji su primili bortezomib i deksametazon.
Another study in 929 multiple myeloma patients whose disease had got worse after previous treatment compared the combination of Kyprolis and dexamethasone with bortezomib and dexamethasone.
U drugom je ispitivanju, koje je obuhvatilo 929 bolesnika oboljelih od multiplog mijeloma čija se bolest pogoršala, uspoređena primjena kombinacije lijeka Kyprolis i deksametazona s bortezomibom i deksametazonom.
For the full list of side effects and restrictions, see the package leaflet.
Potpuni popis nuspojava i ograničenja vezanih uz primjenu potražite u uputi o lijeku.
It considered that the increase in time without the disease getting worse with Kyprolis was clinically meaningful.
Smatra se da je poboljšanje preživljenja bez progresije bolesti koje je uočeno pri primjeni lijeka Kyprolis klinički važno.
How is Kyprolis used?
Kako se Kyprolis koristi?
ADROVANCE with food and drink
ADROVANCE s hranom i pićem
ADROVANCE is effective only if taken when your stomach is empty.
ADROVANCE je djelotvoran samo kada se uzima na prazan želudac.
What ADROVANCE is and what it is used for
Što je ADROVANCE i za što se koristi
Always take ADROVANCE exactly as your doctor or pharmacist has told you.
Uvijek uzmite ADROVANCE točno onako kako Vam je rekao liječnik ili ljekarnik.
It contains important information reminding you how to take ADROVANCE properly.
Ona sadrži važne informacije koje će Vas podsjetiti kako pravilno uzimati ADROVANCE.
Children and adolescents ADROVANCE should not be given to children and adolescents less than 18 years of age.
Djeca i adolescenti ADROVANCE se ne smije davati djeci i adolescentima mlađima od 18 godina.
What ADROVANCE looks like and contents of the pack
Kako ADROVANCE izgleda i sadržaj pakiranja
Talk to your doctor or pharmacist before taking ADROVANCE if:
Obratite se svom liječniku ili ljekarniku prije nego uzmete ADROVANCE ako:
Date of first authorisation: 4 January 2007 Date of latest renewal: 21 November 2011
Datum posljednje obnove odobrenja: 21. studenog 2011.
Since it is not known how long you should take ADROVANCE, you should discuss the need to stay on this medicine with your doctor periodically to determine if ADROVANCE is still right for you.
Budući da nije poznato koliko dugo trebate uzimati ADROVANCE, povremeno biste sa svojim liječnikom trebali razgovarati o potrebi nastavka liječenja ovim lijekom kako biste utvrdili je li ADROVANCE i dalje dobar lijek za Vas.
Frequencies are defined as: very common (≥1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000)
Učestalost nuspojava definirana je kategorijama: vrlo često (≥1/10), često (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (< 1/10 000).
The safety and efficacy of ADROVANCE in children less than 18 years of age have not been established.
Sigurnost i djelotvornost lijeka ADROVANCE u djece mlađe od 18 godina nisu ustanovljene.
Therefore, caution should be used when these medicines are taken at the same time as ADROVANCE.
Stoga je potreban oprez kada se ti lijekovi uzimaju istodobno s lijekom ADROVANCE.
What you need to know before you take ADROVANCE
Što morate znati prije nego počnete uzimati ADROVANCE
ADROVANCE has no or negligible direct influence on the ability to drive and use machines.
ADROVANCE ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
If you take more ADROVANCE than you should If you take too many tablets by mistake, drink a full glass of milk and contact your doctor immediately.
Ako greškom uzmete previše tableta, popijte punu čašu mlijeka i odmah se obratite liječniku.
Other medicines and ADROVANCE
Drugi lijekovi i ADROVANCE
ADROVANCE is only intended for use in postmenopausal women.
ADROVANCE je namijenjen isključivo ženama u postmenopauzi.
What ADROVANCE is and what it is used for What you need to know before you take ADROVANCE How to take ADROVANCE Possible side effects
Što je ADROVANCE i za što se koristi Što morate znati prije nego počnete uzimati ADROVANCE Kako uzimati ADROVANCE
It is important that you take ADROVANCE for as long as your doctor prescribes the medicine.
Važno je da uzimate ADROVANCE sve dok Vam ga liječnik propisuje.
• Patients should not lie down for at least 30 minutes after taking ADROVANCE and until after the first food of the day.
• Bolesnice ne smiju leći najmanje 30 minuta nakon uzimanja ADROVANCE tablete i dok ne pojedu svoj prvi dnevni obrok.
What is ADROVANCE used for?
Za što se koristi ADROVANCE?
If you stop taking ADROVANCE
Ako prestanete uzimati ADROVANCE
ADROVANCE should not be used during pregnancy.
ADROVANCE se ne smije primjenjivati tijekom trudnoće.
Bone and mineral metabolism Causes of osteoporosis other than oestrogen deficiency and ageing should be considered.
Metabolizam minerala i kostiju Moraju se razmotriti i drugi uzroci osteoporoze osim nedostatka estrogena i starenja.
• ADROVANCE should only be swallowed after getting up for the day with a full glass of water (not less than 200 ml).
• ADROVANCE se mora progutati ujutro, nakon ustajanja, s punom čašom vode (najmanje 200 ml).
An Instruction Card is included in the carton for ADROVANCE.
Kartica s uputama priložena je u kutiji lijeka ADROVANCE.
Remember, take ADROVANCE once each week on that same day for as long as your doctor prescribes it.
Upamtite, uzmite ADROVANCE jedanput na tjedan na isti odabrani dan, onoliko dugo koliko Vam je liječnik propisao.
4) Do not take ADROVANCE at bedtime or before getting up for the day.
4) Nemojte uzimati ADROVANCE navečer prije spavanja niti ujutro prije ustajanja.
How to take ADROVANCE tablets
Kako uzimati ADROVANCE tablete
Your doctor has prescribed ADROVANCE to treat your osteoporosis and because you are at risk of vitamin D insufficiency.
Liječnik Vam je propisao ADROVANCE za liječenje osteoporoze i zato što imate rizik od nedostatka vitamina D.
• Patients should only swallow ADROVANCE whole.
• Bolesnice moraju ADROVANCE tabletu progutati cijelu.
Do not take ADROVANCE
Nemojte uzimati ADROVANCE
These side effects may worsen if patients continue to take ADROVANCE after developing these symptoms.
Spomenute se nuspojave mogu pogoršati nastave li bolesnice uzimati ADROVANCE i nakon pojave opisanih simptoma.
ADROVANCE tablet whole with a full glass of water only (not mineral water) (not less than
ADROVANCE tabletu s punom čašom obične vode (ne mineralne vode) (najmanje 200 ml)
ADROVANCE is only intended for use in postmenopausal women and therefore it should not be used during pregnancy or in breast-feeding women.
ADROVANCE je namijenjen samo ženama u postmenopauzi i zbog toga se ne smije davati trudnicama ni dojiljama.
The content of vitamin D in ADROVANCE is not suitable for correction of vitamin D deficiency.
Količina vitamina D u lijeku ADROVANCE nije primjerena za korekciju nedostatka vitamina D.
ADROVANCE must be taken with water only (not mineral water) at least 30 minutes before the first food, beverage, or medicinal product (including antacids, calcium supplements and vitamins) of the day.
ADROVANCE se mora uzimati samo s vodom (ne mineralnom vodom) najmanje 30 minuta prije uzimanja prvoga dnevnog obroka, napitka ili drugih lijekova (uključujući antacide, nadomjestke kalcija i vitamine).
It is very important to follow instructions 2), 3), 4) and 5) to help the ADROVANCE tablet reach your stomach quickly and help reduce the chance of irritating your gullet (oesophagus - the tube that connects your mouth with your stomach).
Vrlo je važno pridržavati se uputa navedenih pod 2), 3), 4) i 5) kako bi ADROVANCE tableta brzo stigla do želuca i kako bi se smanjila vjerojatnost da će nadražiti jednjak (jednjak je cijev koja spaja usta sa želucem).
If you miss a dose, take only one ADROVANCE tablet on the morning after you remember.
Ako propustite uzeti dozu, uzmite samo jednu ADROVANCE tabletu sljedećeg jutra nakon što se sjetite.
Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP.
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i blisteru iza oznake 'Rok valjanosti' ili kratice 'EXP'.
In case of overdose with ADROVANCE, milk or antacids should be given to bind alendronate.
Dođe li do predoziranja ADROVANCE tabletama, bolesnici se moraju dati mlijeko ili antacidi kako bi vezali alendronat.
When you get out of bed on the day you have chosen, and before taking your first food, drink or other medicines, swallow (do not crush or chew the tablet or allow it to dissolve in your mouth) one ADROVANCE tablet with a full glass of water (not mineral water).
Toga dana neposredno nakon ustajanja, a prije uzimanja bilo kakve hrane, napitka ili drugog lijeka progutajte jednu ADROVANCE tabletu (tabletu nemojte drobiti, žvakati niti dopustiti da se otopi u ustima) s punom čašom obične vode (ne mineralne vode).
ADROVANCE is not recommended for patients with renal impairment where creatinine clearance is less than 35 ml/min (see section 4.2).
ADROVANCE se ne preporučuje bolesnicama s oštećenjem funkcije bubrega u kojih je klirens kreatinina manji od 35 ml/min (vidjeti dio 4.2).
The need for continued treatment should be re-evaluated periodically based on the benefits and potential risks of ADROVANCE on an individual patient basis, particularly after 5 or more years of use.
Na temelju koristi i mogućih rizika primjene lijeka ADROVANCE, potrebu za nastavkom liječenja u svake pojedine bolesnice treba periodički ponovno procijeniti, posebice nakon 5 ili više godina liječenja.
ADROVANCE is a tablet containing the two active substances, alendronic acid (commonly called alendronate) and colecalciferol known as vitamin D3.
ADROVANCE je tableta koja sadrži dvije djelatne tvari, alendronatnu kiselinu (koja se često naziva alendronat) i kolekalciferol, poznat kao vitamin D3.
Hypocalcaemia must be corrected before initiating therapy with ADROVANCE (see section 4.3).
Prije početka liječenja lijekom ADROVANCE mora se korigirati hipokalcijemija (vidjeti dio 4.3).
If you forget to take ADROVANCE
Ako ste zaboravili uzeti ADROVANCE
You may be advised to have a dental check-up before starting treatment with ADROVANCE.
Liječnik će Vam možda savjetovati da obavite kontrolu kod stomatologa prije nego počnete uzimati ADROVANCE.
It is likely that food and beverages (including mineral water) will make ADROVANCE less effective if taken at the same time.
Moguće je da će hrana i piće (uključujući mineralnu vodu) smanjiti djelotvornost lijeka ADROVANCE ako se uzmu u isto vrijeme kad i lijek.
You should not take ADROVANCE if you are or think you may be pregnant, or if you are breast-feeding.
• žgaravica; otežano gutanje; bolno gutanje; vrijedovi (čirevi) na jednjaku (cijevi koja spaja usta sa želucem) koji mogu uzrokovati bol u prsištu, žgaravicu ili otežano ili bolno gutanje.
ADROVANCE is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D insufficiency.
ADROVANCE je indiciran za liječenje osteoporoze u žena u postmenopauzi s rizikom od nedostatka vitamina D.
Irritation, inflammation or ulceration of the gullet (oesophagus - the tube that connects your mouth with your stomach) often with symptoms of chest pain, heartburn, or difficulty or pain upon swallowing may occur, especially if patients do not drink a full glass of water and/or if they lie down less than 30 minutes after taking ADROVANCE.
Mogu se pojaviti nadražaj, upala ili vrijedovi (čirevi) na jednjaku (cijev koja spaja usta sa želucem), često sa simptomima boli u prsištu, žgaravice ili otežanog ili bolnog gutanja, posebno u bolesnica koje ADROVANCE tabletu ne popiju s punom čašom vode i/ili u onih koje legnu ne pričekavši da prođe 30 minuta od uzimanja lijeka.
The mean half-life of vitamin D3 in the serum following an oral dose of ADROVANCE (70 mg/2,800 IU) is approximately 24 hours.
Prosječan poluvijek vitamina D3 u serumu nakon peroralne primjene lijeka ADROVANCE (70 mg/2800 IU) iznosi približno 24 sata.
Patients may experience certain adverse reactions (for example blurred vision, dizziness and severe bone muscle or joint pain (see section 4.8)) that may influence the ability to drive and use machines.
Bolesnice mogu razviti određene nuspojave (npr. zamagljen vid, omaglicu i jake bolove u kostima, mišićima ili zglobovima (vidjeti dio 4.8)) koje mogu utjecati na sposobnost upravljanja vozilima i rada sa strojevima.
Due to the nature of the disease process in osteoporosis, ADROVANCE is intended for long-term use.
Zbog prirode bolesti, tj. razvoja osteoporoze, ADROVANCE je lijek za dugotrajnu primjenu.
As well as your treatment with ADROVANCE, your doctor may suggest you make changes to your lifestyle to help your condition, such as:
Uz to što Vam je propisao ADROVANCE, liječnik Vam može predložiti promjene nekih životnih navika koje mogu poboljšati
In patients with known Barrett's oesophagus, prescribers should consider the benefits and potential risks of alendronate on an individual patient basis.
U bolesnica s dijagnozom Barretovog jednjaka, liječnici koji propisuju ADROVANCE moraju procijeniti korist liječenja alendronatom u odnosu na moguće rizike u svake pojedine bolesnice.
There have been side effects (for example blurred vision, dizziness and severe bone, muscle or joint pain) reported with ADROVANCE that may affect your ability to drive or operate machinery (see section 4).
Prijavljene su nuspojave na ADROVANCE (npr. zamagljen vid, omaglica i jaki bolovi u kostima, mišićima ili zglobovima) koje mogu utjecati na Vašu sposobnost upravljanja vozilima ili rada sa strojevima (pogledajte dio 4.).
ADROVANCE contains lactose and sucrose.
ADROVANCE sadrži laktozu i saharozu.
• ADROVANCE should not be taken at bedtime or before arising for the day.
• ADROVANCE se ne smije uzimati navečer prije spavanja niti ujutro prije ustajanja.
There is important additional information about how to take ADROVANCE in the package leaflet.
Važne dodatne informacije o tome kako uzimati ADROVANCE navedene su u Uputi o lijeku.
What ADROVANCE contains
Što ADROVANCE sadrži
ADROVANCE should not be used during breast-feeding.
ADROVANCE se ne smije primjenjivati tijekom dojenja.
What is ADROVANCE?
Što je ADROVANCE?
Patients should be instructed that if they miss a dose of ADROVANCE they should take one tablet on the morning after they remember.
Bolesnice treba poučiti da, propuste li uzeti ADROVANCE tabletu, istu moraju uzeti sljedećeg jutra.
It is important to maintain good oral hygiene when being treated with ADROVANCE.
Tijekom liječenja lijekom ADROVANCE važno je održavati dobru higijenu usne šupljine.
Take one ADROVANCE tablet once a week.
Uzmite jednu ADROVANCE tabletu jedanput na tjedan.
The bioavailability of the 5,600 IU vitamin D3 in ADROVANCE is similar to 5,600 IU vitamin D3 administered alone.
Bioraspoloživost 5600 IU vitamina D3 u lijeku ADROVANCE slična je onoj kod primjene 5600 IU samog vitamina D3.
How to take ADROVANCE
Kako uzimati ADROVANCE
6) After swallowing your ADROVANCE tablet, wait at least 30 minutes before taking your first food, drink, or other medicine of the day, including antacids, calcium supplements and vitamins.
6) Nakon što progutate ADROVANCE tabletu, najmanje 30 minuta nemojte jesti, piti niti uzimati druge lijekove, uključujući antacide (lijekove za sniženje želučane kiseline), nadomjestke kalcija i vitamine.
ADROVANCE 70 mg/2,800 IU tablets EU/1/06/364/001 - 2 tablets
ADROVANCE 70 mg/2800 IU tablete EU/1/06/364/001 - 2 tablete
Every week, take one ADROVANCE tablet on your chosen day.
Svakoga tjedna, u odabrani dan, uzmite jednu ADROVANCE tabletu.
It is likely that certain medicines or food additives may prevent the vitamin D in ADROVANCE from getting into your body, including artificial fat substitutes, mineral oils, the weight loss medicine, orlistat, and the cholesterol-lowering medicines, cholestyramine and colestipol.
Moguće je da neki lijekovi ili dodaci prehrani, uključujući umjetne zamjenske masti, mineralna ulja, lijekove za smanjenje tjelesne težine, orlistat te lijekove za snižavanje kolesterola kolestiramin i kolestipol, mogu spriječiti da vitamin D koji je sadržan u lijeku ADROVANCE uđe u Vaše tijelo.
Patients in the Vitamin D3 2,800 group received ADROVANCE (70 mg/2,800 IU) (n=299) and patients in the Vitamin D3 5,600 group received ADROVANCE (70 mg/2,800 IU) plus an additional 2,800 IU vitamin D3 (n=309) once a week; additional vitamin D supplements were allowed.
Bolesnice u skupini Vitamin D3 2800 uzimale su ADROVANCE (70 mg/2800 IU) (n=299) jedanput na tjedan, dok su bolesnice u skupini Vitamin D3 5600 uzimale ADROVANCE (70 mg/2800 IU) uz dodatak 2800 IU vitamina D3 (n=309) jedanput na tjedan; bio je dopušten dodatni nadomjestak vitamina D.
In patients with these conditions, serum calcium and symptoms of hypocalcaemia should be monitored during therapy with ADROVANCE.
U bolesnica s ovim stanjima se tijekom liječenja lijekom ADROVANCE moraju pratiti koncentracija kalcija u serumu i simptomi hipokalcijemije.
The bioavailability of the 2,800 IU vitamin D3 in ADROVANCE is similar to 2,800 IU vitamin D3 administered alone.
Bioraspoloživost 2800 IU vitamina D3 u lijeku ADROVANCE slična je onoj kod primjene 2800 IU samog vitamina D3.
In this study, mean 25-hydroxyvitamin D levels in patients with vitamin D insufficiency at baseline (25-hydroxyvitamin D, 22.5 to 37.5 nmol/l [9 to < 15 ng/ml]) increased from 30 nmol/l (12.1 ng/ml) to 40 nmol/l (15.9 ng/ml) at week 15 in the ADROVANCE (70 mg/2,800 IU) group (n=75) and decreased from 30 nmol/l (12.0 ng/ml) at baseline to 26 nmol/l (10.4 ng/ml) at week 15 in the alendronate-only group (n=70).
U ovom su ispitivanju srednje vrijednosti 25-hidroksivitamina D u bolesnica s početnim nedostatkom vitamina D (25-hidroksivitamin D, 22,5 do 37,5 nmol/l [9 do < 15 ng/ml]) liječenih ADROVANCE tabletama (70 mg/2800 IU) (n=75) porasle s početnih 30 nmol/l (12,1 ng/ml) na 40 nmol/l (15,9 ng/ml) u 15. tjednu, dok su u skupini koja je primala samo alendronat one u 15. tjednu pale s početnih 30 nmol/l (12,0 ng/ml) na 26 nmol/l (10,4 ng/ml) (n=70).
The alendronate component in the ADROVANCE (70 mg/2,800 IU) combination tablet and the ADROVANCE (70 mg/5,600 IU) combination tablet is bioequivalent to the alendronate 70 mg tablet.
Alendronat sadržan u kombiniranoj ADROVANCE (70 mg/2800 IU) tableti i kombiniranoj ADROVANCE (70 mg/5600 IU) tableti bioekvivalentan je alendronatu u tableti od 70 mg.
Patients received the lower strength (70 mg/2,800 IU) of ADROVANCE (n=350) or FOSAMAX (alendronate) 70 mg (n=332) once a week; additional vitamin D supplements were prohibited.
Bolesnice su jedanput na tjedan primale ADROVANCE u nižoj dozi (70 mg/2800 IU) (n=350) ili FOSAMAX (alendronat) u dozi od 70 mg (n=332); dodatni nadomjestak vitamina
BLISTER FOR ADROVANCE 70 mg/5,600 IU
BLISTER ZA ADROVANCE 70 mg/5600 IU
BLISTER FOR ADROVANCE 70 mg/2,800 IU
BLISTER ZA ADROVANCE 70 mg/2800 IU
ADROVANCE 70 mg/5,600 IU tablets
ADROVANCE 70 mg/5600 IU tablete
ADROVANCE 70 mg/5,600 IU tablets EU/1/06/364/006 - 2 tablets EU/1/06/364/007 - 4 tablets EU/1/06/364/008 - 12 tablets
ADROVANCE 70 mg/5600 IU tablete EU/1/06/364/006 - 2 tablete EU/1/06/364/007 - 4 tablete EU/1/06/364/008 - 12 tableta
EU/1/06/364/001 (2 tablets) EU/1/06/364/002 (4 tablets) EU/1/06/364/003 (6 tablets) EU/1/06/364/004 (12 tablets)
EU/1/06/364/001 (2 tablete) EU/1/06/364/002 (4 tablete) EU/1/06/364/003 (6 tableta) EU/1/06/364/004 (12 tableta)
ADROVANCE 70 mg/5,600 IU tablets are available as modified rectangle-shaped, white to off-white tablets marked with an outline of a bone image on one side and ‘270' on the other.
ADROVANCE 70 mg/5600 IU tablete su bijele do gotovo bijele tablete oblika preinačenog pravokutnika s oznakom kosti na jednoj strani i utisnutom oznakom '270' na drugoj.
The equivalence of intake of 5,600 IU of vitamin D3 weekly in ADROVANCE to daily dosing of vitamin D 800 IU has not been studied.
Nije ispitano odgovara li tjedna doza vitamina D3 od 5600 IU u lijeku ADROVANCE dnevnom doziranju vitamina D od 800 IU.
The percentage of patients with vitamin D deficiency (serum 25-hydroxyvitamin D  22.5 nmol/l [ 9 ng/ml]) was significantly reduced by 92 % with ADROVANCE (70 mg/2,800 IU) vs. alendronate-only (1 % vs 13 %, respectively).
Postotak ispitanica s manjkom vitamina D (25-hidroksivitamin D < 22,5 nmol/l [< 9 ng/ml] u serumu) značajno je smanjen za 92% u skupini koja je primala ADROVANCE (70 mg/2800 IU) naspram skupine koja je primala samo alendronat (1% naspram 13%).
5) If you develop difficulty or pain upon swallowing, chest pain, or new or worsening heartburn, stop taking ADROVANCE and contact your doctor.
5) Prestanite uzimati ADROVANCE i obratite se svom liječniku ako osjetite teškoće ili bol pri gutanju, bol u prsištu, žgaravicu ili pogoršanje žgaravice.
ADROVANCE 70 mg/5,600 IU tablets are available in packs containing 2, 4 or 12 tablets.
ADROVANCE 70 mg/5600 IU tablete dostupne su u pakiranjima koja sadrže 2, 4 ili 12 tableta.
ADROVANCE 70 mg/2,800 IU tablets ADROVANCE 70 mg/5,600 IU tablets
ADROVANCE 70 mg/2800 IU tablete ADROVANCE 70 mg/5600 IU tablete
EU/1/06/364/003 - 6 tablets
EU/1/06/364/003 - 6 tableta
ADROVANCE is not recommended for patients with renal impairment where creatinine clearance is less than 35 ml/min, due to lack of experience.
Zbog nedostatka iskustva ADROVANCE se ne preporučuje bolesnicama s oštećenjem funkcije bubrega u kojih je klirens kreatinina manji od 35 ml/min.
EU/1/06/364/006 (2 tablets) EU/1/06/364/007 (4 tablets) EU/1/06/364/008 (12 tablets)
EU/1/06/364/006 (2 tablete) EU/1/06/364/007 (4 tablete) EU/1/06/364/008 (12 tableta)
ADROVANCE 70 mg/5,600 IU tablets Aluminium/aluminium blisters, in cartons containing 2, 4 or 12 tablets.
ADROVANCE 70 mg/5600 IU tablete Aluminij/aluminij blisteri u kutijama sa 2, 4 ili 12 tableta.
The equivalence of intake of 2,800 IU of vitamin D3 weekly in ADROVANCE to daily dosing of vitamin D 400 IU has not been studied.
Nije ispitano odgovara li tjedna doza vitamina D3 od 2800 IU u lijeku ADROVANCE dnevnom doziranju vitamina D od 400 IU.
ADROVANCE 70 mg/2,800 IU tablets are available as modified capsule-shaped, white to off-white tablets marked with an outline of a bone image on one side and ‘710' on the other.
ADROVANCE 70 mg/2800 IU tablete su bijele do gotovo bijele tablete oblika preinačene kapsule s oznakom kosti na jednoj strani i utisnutom oznakom '710' na drugoj.
ADROVANCE 70 mg/2,800 IU tablets
ADROVANCE 70 mg/2800 IU tablete
EU/1/06/364/004 - 12 tablets
EU/1/06/364/004 - 12 tableta
ADROVANCE 70 mg/2,800 IU tablets Aluminium/aluminium blisters, in cartons containing 2, 4, 6 or 12 tablets.
ADROVANCE 70 mg/2800 IU tablete Aluminij/aluminij blisteri u kutijama sa 2, 4, 6 ili 12 tableta.
EU/1/06/364/002 - 4 tablets
EU/1/06/364/002 - 4 tablete
ADROVANCE 70 mg/2,800 IU tablets are available in packs containing 2, 4, 6 or 12 tablets.
ADROVANCE 70 mg/2800 IU tablete dostupne su u pakiranjima koja sadrže 2, 4, 6 ili 12 tableta.
Olestra, mineral oils, orlistat, and bile acid sequestrants (e.g. cholestyramine, colestipol) may impair the absorption of vitamin D.
Apsorpciju vitamina D mogu smanjiti olestra, mineralna ulja, orlistat i ionski izmjenjivači (npr. kolestiramin i kolestipol).